...
首页> 外文期刊>Regulatory Affairs Journal- Devices >Activities to improve the regulatory framework for companion diagnostics step up
【24h】

Activities to improve the regulatory framework for companion diagnostics step up

机译:加强改善伴随诊断的监管框架的活动

获取原文
获取原文并翻译 | 示例
           

摘要

Personalised medicine aims to provide the right treatment to the right patient, at the right dose and at the right time.It is a cutting-edge approach that involves co-ordinating diagnostic and therapeutic tools to tailor medicines to the individual characteristics of each patient, thereby improving the safety and efficacy of the therapy and potentially reducing healthcare and clinical trial costs.Personalised medicine is a very promising field. But there are challenges involved in having to co-develop, in parallel with a drug, a companion diagnostic that can determine which patients may or may not respond favourably to that drug.
机译:个性化药物旨在以正确的剂量和正确的时间为正确的患者提供正确的治疗。这是一种前沿方法,涉及协调诊断和治疗工具,以根据每个患者的个性化特点定制药物,从而提高该疗法的安全性和有效性,并有可能降低医疗保健和临床试验成本。个性化医学是一个非常有前途的领域。但是,与一种药物同时开发一种共同的诊断方法会带来一些挑战,这种诊断方法可以确定哪些患者可能对该药物产生有利或不利的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号